Background illustration for clinical trials search

Paid Clinical Trials Grand Rapids

Discover 476 paid clinical trials in Grand Rapids, Michigan. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Study of APG-3288 in Relapsed/Refractory Blood Cancers

for
Relapsed/Refractory Hematological Malignancies,
Location: Grand Rapids MI, East Brunswick NJ, Los Angeles CA
Sponsor: Ascentage Pharma Group Inc.

Sex: All

Age: 18+

Code: NCT07424833

Phase1, Recruiting

A Study to Investigate the Safety and Efficacy of KQB548 in Participants With Advanced Solid Malignancies

for
Solid Tumor Malignancies
Location: Grand Rapids MI, Cincinnati OH, Fairfax VA, Irving TX,
Sponsor: Kumquat Biosciences Inc.

Sex: All

Age: 18+

Code: NCT07207707

Phase1, Recruiting

TLN-372 in Advanced KRAS Mutant Solid Tumors

for
KRAS Mutant Solid Tumors
Location: Grand Rapids MI, Toronto, St Louis MO, Nashville TN,
Sponsor: Treeline Biosciences, Inc.

Sex: All

Age: 18+

Code: NCT07204340

Phase1, Recruiting

A Study of ZW251 in Participants With Advanced Solid Tumors

for
Hepatocellular Carcinoma,
Location: Grand Rapids MI, Louisville KY, Hackensack NJ,
Sponsor: Zymeworks BC Inc.

Sex: All

Age: 18+

Code: NCT07164313

Phase1, Recruiting

A Study of JNJ-95804306 for Relapsed or Refractory Hematological Malignancies

for
Hematologic Neoplasms
Location: Grand Rapids MI, Indianapolis IN, Nashville TN,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT07572006

Phase1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors

for
Advanced Solid Tumor
Location: Grand Rapids MI, Detroit MI, Madison WI, Cleveland OH,
Sponsor: BioNTech SE

Sex: All

Age: 18+

Code: NCT07070232

Phase1, Phase2, Recruiting

A Study to Assess the Safety, Tolerability, and Antileukemic Activity of Debio 1562M in Participants With Acute Myeloid Leukemia (AML)

for
Acute Myeloid Leukemia
Location: Grand Rapids MI, Chicago IL, Columbus OH, Buffalo NY,
Sponsor: Debiopharm International SA

Sex: All

Age: 18+

Code: NCT06969430

Phase1, Phase2, Recruiting

Study to Assess GTAEXS617 in Participants With Advanced Solid Tumors

for
Head and Neck Squamous Cell Carcinoma (HNSCC),
Location: Grand Rapids MI, Columbus OH, New York NY,
Sponsor: Exscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc.

Sex: All

Age: 18+

Code: NCT05985655

Phase1, Phase2, Recruiting

A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors

for
Gastric or Gastro-esophageal Junction (GEJ) Adenocarcinoma,
Location: Grand Rapids MI, Indianapolis IN, Fairfax VA, Durham NC,
Sponsor: Astellas Pharma Global Development, Inc.

Sex: All

Age: 18+

Code: NCT07488676

Phase1, Phase2, Recruiting

TLN-121 in Relapsed or Refractory Non-Hodgkin Lymphomas

for
Lymphoma, Lymphoma, Non Hodgkin
Location: Grand Rapids MI, St Louis MO, Nashville TN,
Sponsor: Treeline Biosciences, Inc.

Sex: All

Age: 18+

Code: NCT07082803

Phase1, Recruiting

A Clinical Study to Test if an Investigational Treatment Called BNT314 When Used in Combination With Another Investigational Treatment Pumitamig (BNT327) and Chemotherapy, is Beneficial and Safe for Patients With Advanced Colorectal Cancer

for
Metastatic Colorectal Cancer
Location: Grand Rapids MI, Cleveland OH, New Haven CT, Houston TX
Sponsor: BioNTech SE

Sex: All

Age: 18+

Code: NCT07079631

Phase1, Phase2, Recruiting

Study of AUBE00 in Patients With Solid Tumors

for
Solid Tumors
Location: Grand Rapids MI, Houston TX
Sponsor: Chugai Pharmaceutical

Sex: All

Age: 18+

Code: NCT07030959

Phase1, Recruiting

A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors

for
HR+ Breast Cancer, Triple Negative Breast Cancer (TNBC),
Location: Grand Rapids MI, Cleveland OH, Iowa City IA,
Sponsor: NiKang Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT07029399

Phase1, Recruiting

AVA6103 in Subjects With Locally Advanced or Metastatic Selected Solid Tumors

for
Vulvar Adenocarcinoma, PDAC - Pancreatic Ductal Adenocarcinoma,
Location: Grand Rapids MI, Fairfax VA, Irving TX
Sponsor: Avacta Life Sciences Ltd

Sex: All

Age: 18+

Code: NCT07454642

Phase1, Recruiting

An Early Phase Trial of RPTR-1-201 in Advanced Solid Tumors

for
Advanced Malignant Solid Tumor
Location: Grand Rapids MI
Sponsor: Repertoire Immune Medicines

Sex: All

Age: 18+

Code: NCT07293754

Phase1, Phase2, Recruiting

Dose Escalation and Expansion Study of BH3120 Alone or With Pembrolizuamb in Advanced or Metastatic Solid Tumors

for
Advanced or Metastatic Solid Tumors
Location: Grand Rapids MI, Cincinnati OH, Tampa FL,
Sponsor: Hanmi Pharmaceutical Company Limited

Sex: All

Age: 18+

Code: NCT06234397

Phase1, Recruiting

Study of ON 123300 in Patients With Advanced Cancer

for
Solid Tumors, Adult
Location: Grand Rapids MI, Greenville SC, Dallas TX
Sponsor: Traws Pharma, Inc.

Sex: All

Age: 18+

Code: NCT04739293

Phase1, Recruiting

A Study of Pasritamig (JNJ-78278343) in Combination With Other Agents for Metastatic Prostate Cancer

for
Metastatic Castration-resistant Prostate Neoplasms,
Location: Grand Rapids MI, St Louis MO, Philadelphia PA,
Sponsor: Janssen Research & Development, LLC

Sex: Male

Age: 18+

Code: NCT05818683

Phase1, Recruiting

A Study of PRMT5 Inhibitor BAY 3713372 in Participants With MTAP-deleted Solid Tumors

for
MTAP-deleted Solid Tumors
Location: Grand Rapids MI, Milwaukee WI, Nashville TN,
Sponsor: Bayer

Sex: All

Age: 18+

Code: NCT06914128

Phase1, Phase2, Recruiting

STC-15 as a Part of Combination Therapy With Toripalimab in Selected Advanced Cancers and as Monotherapy in Participants With Selected Sarcomas

for
Solid Tumor, Sarcoma, Leiomyosarcoma,
Location: Grand Rapids MI, Fairfax VA, Lake Success NY, Boston MA,
Sponsor: STORM Therapeutics LTD

Sex: All

Age: 18+

Code: NCT06975293

Phase1, Phase2, Recruiting